Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.
Ophthalmol Ther
; 9(4): 913-915, 2020 Dec.
Article
en En
| MEDLINE
| ID: mdl-32920777
The authors of the above mentioned article would like to highlight the following corrections, based upon recent changes to the FDA label and guidance on the use of belamaf.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
Idioma:
En
Revista:
Ophthalmol Ther
Año:
2020
Tipo del documento:
Article
País de afiliación:
Estados Unidos